Live Breaking News & Updates on முள் எண்

Stay updated with breaking news from முள் எண். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jaguar Health, Inc. Reports 2021 First Quarter Financial Results


Jaguar Health, Inc. Reports 2021 First Quarter Financial Results
ACCESSWIRE
17 May 2021, 22:05 GMT+10
First quarter 2021 Mytesi gross sales and net sales were approximately $4.6 million and approximately $1.2 million, increases of 250% and 43%, respectively
Company to host investor webcast Monday, May 17th at 8:30 a.m. Eastern regarding first quarter 2021 financials & business updates
SAN FRANCISCO, CA / ACCESSWIRE / May 17, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today reported consolidated first quarter 2021 financial results.
2021 First Quarter Company Financial Results:
Mytesi
® Net Product Revenue: Mytesi net sales during the
first quarter of 2021 were approximately $1.2 million and $0.9 million in the first quarter of 2020. This first quarter 2021 result represents an increase of approximately 43% of the same period in 2020, or $0.3 million quarter over quarter. The increase in sales of Mytesi is due to the co ....

United States , Peter Hodge , First Quarter Company Financial , Jaguar Health Inc , Napo Pharmaceuticals Inc , Jaguar Health , Quarter Company Financial Results , Net Product Revenue , Wholesaler Acquisition Cost , Gross Product Revenue , Mytesi Prescription Volume , Total Mytesi , Product Revenue , Warrant Exercise , Preferred Stock Amendment Agreement , Seriesb Convertible Preferred Stock , Bridge Warrants , Seriesb Convertible Preferred , Exchange Note , Regarding Use , Access Link , Pin Number , Napo Pharmaceuticals , Prescribing Information , United States Wire Group , ஒன்றுபட்டது மாநிலங்களில் ,

Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, June 11, 2021 and Encourages All Shareholders to Vote


Jaguar Health Announces Adjournment of Annual Meeting of Stockholders Until Friday, June 11, 2021 and Encourages All Shareholders to Vote
ACCESSWIRE
14 May 2021, 22:43 GMT+10
Based on a preliminary review of votes cast, over 80% have voted in favor of Proposals 2, 3, 4 & 6
Meeting scheduled to reconvene June 11, 2021 at 8:30 AM Pacific Standard Time to provide time to reach quorum
Reminder: Jaguar to host investor webcast Monday, May 17th at 8:30 AM Eastern Time regarding Q1 2021 financials & business updates
SAN FRANCISCO,
CA / ACCESSWIRE / May 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced that its Annual Meeting of Stockholders held on May 13, 2021 (the Annual Meeting ) was adjourned due to a lack of quorum. The adjourned meeting will be held at 8:30 a.m. Pacific Standard Time/11:30 a.m. Eastern Standard Time on Friday, June 11, 2021, at the offices of the Company at 200 Pine Street, Suite 400, San Francis ....

San Francisco , United States , Lisa Conte , Peter Hodge , Company Proxy Statement , Company Third , Jaguar Health Inc , Napo Pharmaceuticals Inc , Standard Time , Jaguar Health , Annual Meeting , Common Stock , Third Amended , Restated Certificate , Proxy Statement , Access Link , Pin Number , Napo Pharmaceuticals , Prescribing Information , சான் பிரான்சிஸ்கோ , ஒன்றுபட்டது மாநிலங்களில் , லிசா கொண்டே , பீட்டர் ஹாட்ஜ் , நிறுவனம் ப்ராக்ஸி அறிக்கை , நிறுவனம் மூன்றாவது , ஜாகுவார் ஆரோக்கியம் இன்க் ,

Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results


Galmed Pharmaceuticals Provides Business Updates and Reports First Quarter 2021 Financial Results
USA - English
News provided by
Share this article
Share this article
TEL AVIV, Israel, May 13, 2021 /PRNewswire/ Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ( Galmed or the Company ), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis, reports financial results for the three months ended March 31, 2021. The Company will host a conference call and webcast at 08:30 ET today.
Recent Clinical & Scientific Developments
Histology Results from approximately one-third of the study population (~ 50 subjects) of the open label part of the ARMOR Phase 3 study with higher exposure of Aramchol are expected to be available in Q4 2021. ....

Hebrew University , Toll International , Galmed Pharmaceuticals Ltd , Prnewswire Galmed Pharmaceuticals Ltd , National Medical Products Administration , Investigational New Drug , First Quarter , Toll Free , Pin Number , Thursday May , Non Alcoholic Steatohepatitis , Fast Track , Looking Statements , Annual Report , Cash Flows , ஹீப்ரு பல்கலைக்கழகம் , சுங்கவரி சர்வதேச , முதல் காலாண்டு , சுங்கவரி இலவசம் , முள் எண் , வியாழன் இருக்கலாம் , வேகமாக டிராக் , பார்க்கிறது அறிக்கைகள் , ஆண்டு அறிக்கை , பணம் பாய்கிறது ,